Gallopamil

This classification denotes a calcium channel blocker with the molecular formula C28H40N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 39WPC8JHR8, chemically known as 5-((3,4-dimethoxyphenethyl)methylamino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile but generally known as gallopamil, which bears US NIH Compound Identifier 1234. European Medicines Agency schedules Gallopamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07874MIG. The term GALLOPAMIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules gallopamil in its Anatomical Therapeutic Chemical (ATC) Classification. GALLOPAMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gallopamil under HS 29269095 and SITC 51484. As of Q4 2014, GALLOPAMIL remains the US FDA Preferred Term for this commodity. Gallopamil bears US NLM identifiers UMLS ID C0016986 and NCI Concept Code C83725. SMILES: O(c1cc(C(C(C)C)(CCCN(CCc2cc(OC)c(OC)cc2)C)C#N)cc(OC)c1OC)C.